PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 21, 2026Acta chirurgica Belgica0 citations

Glycated Hemoglobin as a Long-Term Predictor of Cardiovascular Outcomes in Patients Undergoing Carotid Endarterectomy

View Full Paper
RPRaquel Pinheiro-SilvaUniversidade do PortoAFAndré C. FerreiraFernando Pessoa UniversityLOLuís OrelhasHospitais da Universidade de Coimbra

Key Result

HbA1c serves as a useful and accessible biomarker for vascular risk stratification in patients undergoing carotid endarterectomy.

Key Points

  • Evaluate the effectiveness of glycated hemoglobin as a predictor for cardiovascular outcomes in patients undergoing carotid endarterectomy.
  • Analysis of HbA1c as a biomarker
  • Assessment of cardiovascular risk
  • Observation of patient outcomes post-CEA
  • HbA1c correlates with vascular risk levels
  • Higher HbA1c is linked to worse cardiovascular outcomes

Structured PICO

Does HbA1c predict long-term cardiovascular outcomes in patients undergoing carotid endarterectomy?

P
Population
Patients undergoing carotid endarterectomy (CEA)
I
Intervention
Glycated Hemoglobin (HbA1c) measurement
O
Outcome
Long-term cardiovascular outcomes

HbA1c may serve as a useful biomarker for long-term vascular risk stratification in patients undergoing carotid endarterectomy.

Abstract

HbA1c appears to be a useful, accessible biomarker for vascular risk stratification in patients undergoing CEA.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Pinheiro-Silva et al. (2026) studied this question. HbA1c serves as a useful and accessible biomarker for vascular risk stratification in patients undergoing carotid endarterectomy.

synapsesocial.com/papers/69994ba9873532290d01fc92https://doi.org/10.1080/00015458.2026.2631992
Ask AI
Helpful
Bookmark
Share
View Full Paper